⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL354889 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL465749 | 0.96 | — | — | |
| Bromide SCHEMBL10728305 | 0.96 | — | — | |
| Guanidine SCHEMBL5531666 | 0.73 | — | — | |
| SCHEMBL4113340 | 0.72 | — | — | |
| Guanidine SCHEMBL19644046 | 0.70 | — | — | |
| Guanidine SCHEMBL28861357 | 0.67 | — | — | |
| SCHEMBL546583 | 0.67 | — | — | |
| SCHEMBL3074219 | 0.67 | — | — | |
| SCHEMBL10424357 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118632605-A | Perovskite thin film and perovskite solar cell | 中南大学 | 2024-09-10 | — | — | CN | claimed |
| CN-112490369-A | Preparation method of semiconductor material, perovskite semiconductor device and preparation method thereof | 北京大学深圳研究生院 | 2021-03-12 | — | — | CN | claimed |
| US-10309974-B2 | Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease | CEDARS-SINAI MEDICAL CENTER (US) | 2019-06-04 | — | — | US | claimed |
| US-20180136232-A1 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | CEDARS-SINAI MEDICAL CENTER (US) | 2018-05-17 | — | — | US | claimed |
| US-20170328915-A1 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | CEDARS-SINAI MEDICAL CENTER (US) | 2017-11-16 | — | — | US | claimed |
| US-20160333081-A1 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | THE GENERAL HOSPITAL CORPORATION (US) | 2016-11-17 | — | — | US | claimed |
| WO-2015116896-A1 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | THE GENERAL HOSPITAL CORPORATION (US) | 2015-08-06 | — | — | WO | claimed |
| US-20140308676-A1 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2014-10-16 | — | — | US | claimed |
| US-8569005-B2 | Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases | UNIVERSITY OF SOUTH CAROLINA (US) | 2013-10-29 | — | — | US | claimed |
| EP-2638401-A2 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | The Johns Hopkins University (US) | 2013-09-18 | — | — | EP | claimed |
| US-20100151506-A1 | Chloroacetamidine Based Inhibitors and Activity Based Probes for the Protein Arginine Methytransferases | UNIVERSITY OF SOUTH CAROLINA (US) | 2010-06-17 | — | — | US | claimed |
| WO-2009127048-A1 | METHOD OF TREATING DEMYELINATING DIESASE | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-10-22 | — | — | WO | claimed |
| EP-0724435-B1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | SEARLE & CO (US) | 2002-08-14 | — | — | EP | claimed |
| US-5821267-A | MODULATING THE INDUCIBLE ISOFORM OVER THE CONSTITUTIVE; HYPERTENSIVE, ANTIARTHRITIC AND DIABETIC AGENTS; THERAPY WITH CYTOKINES; TOXIC AND SEPTIC SHOCK | G.D. SEARLE & CO. (US) | 1998-10-13 | — | — | US | claimed |
| EP-0724435-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-08-07 | — | — | EP | claimed |
| WO-1995011014-A1 | AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1995-04-27 | — | — | WO | claimed |
| US-4713490-A | Process for the preparation of alkylthioacetamidines | BAYER AKTIENGESELLSCHAFT (DE) | 1987-12-15 | — | — | US | claimed |
| EP-0184110-A2 | Process for the preparation of alkylthio-acetamidines | BAYER AG (DE) | 1986-06-11 | — | — | EP | claimed |
| US-4522763-A | STARTING MATERIALS FOR CROP PROTECTION AGENTS AND SELECTIVE HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1985-06-11 | — | — | US | claimed |
| US-4443629-A | AMIDINES, HYDRAZINE HYDRATE, SOLVENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1984-04-17 | — | — | US | claimed |